Actinogen Medical: Innovative Alzheimer's Treatment Entering Phase 2 Trial

Jun. 17, 2016
Dave Gentry, host of "The RedChip Money Report", interviews Dr. Bill Ketelbey, CEO of Actinogen Medical (ASX: ACW). Actinogen Medical (“ASX:ACW”, the ...

 Read More


"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market